MiR-143 induces expression of AIM2 and ASC in jurkat cell line

Iranian Journal of Immunology

Volumn 10, Issue 2, 2013, Pages 103-109

  Momeni, Mohammad ^a   Mirzaei, Mohammad Reza ^a   Zainodini, Nahid ^a   Hassanshahi, Gholamhossein ^a   Arababadi, Mohammad Kazemi ^a  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

AIM2; ASC; Jurkat cell; MiR 143

Indexed keywords

ABSENT IN MELANOMA 2; APOPTOSIS ASSOCIATED SPECK LIKE PROTEIN CONTAINING A CASPASE RECRUITMENT DOMAIN; BETA ACTIN; CELL PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INFLAMMASOME; MESSENGER RNA; MICRORNA 143; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE;

APOPTOSIS; CYTOSKELETAL PROTEINS; DNA REPAIR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMASOMES; JURKAT CELLS; MICRORNAS; NUCLEAR PROTEINS; UP-REGULATION;

EID: 84881243070     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Barber GN. Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses. Curr Opin Immunol. 2011; 23:10-20.
2. Case CL. Regulating caspase-1 during infection: roles of NLRs, AIM2, and ASC. Yale J Biol Med. 2011; 84:333-43.
3. Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes in health and disease. Nature. 2012; 481:278-86.
4. Jr Ode F, Moore CS, Kennedy TE, Antel AP, Bar Or A, Dhaunchak AS. MicroRNA dysregulation in multiple sclerosis. Front Genet. 2012; 3:311.
5. Nazarov PV, Reinsbach SE, Muller A, Nicot N, Philippidou D, Vallar L, et al. Interplay of microRNAs, transcription factors and target genes: linking dynamic expression changes to function. Nucleic Acids Res. 2013;41:2817-31.
6. Ambros V. The functions of animal microRNAs. Nature. 2004;431:350-5.
7. Schmidt WM, Spiel AO, Jilma B, Wolzt M, Muller M. In vivo profile of the human leukocyte microRNA response to endotoxemia. Biochem Biophys Res Commun. 2009; 380:437-41.
8. Shaoqing Y, Ruxin Z, Guojun L, Zhiqiang Y, Hua H, Shudong Y, et al. Microarray analysis of differentially expressed microRNAs in allergic rhinitis. Am J Rhinol Allergy. 2011; 25:242-6.
9. Akao Y, Nakagawa Y, Iio A, Naoe T. Role of microRNA-143 in Fas-mediated apoptosis in human T-cell leukemia Jurkat cells. Leuk Res. 2009;33:1530-8.
10. Arababadi MK, Pourfathollah AA, Jafarzadeh A, Hassanshahi G. Serum levels of Interleukin (IL)-10 and IL-17A in occult HBV infected south-east Iranian patients. Hepat Mon. 2010;10:31-5.
11. Brennan K, Bowie AG. Activation of host pattern recognition receptors by viruses. Curr Opin Microbiol. 2010; 13:503-7.
12. Rathinam VA, Jiang Z, Waggoner SN, Sharma S, Cole LE, Waqqoner L, et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol. 2011;11:395-402.
13. Tsuchiya K, Hara H, Kawamura I, Nomura T, Yamamoto T, Daim S, et al. Involvement of absent in melanoma 2 in inflammasome activation in macrophages infected with Listeria monocytogenes. J Immunol. 2011;185:1186-95.
14. Masters SL. Specific inflammasomes in complex diseases. Clin Immunol. 2013; 147:223-8.
15. Vladimer GI, Marty-Roix R, Ghosh S, Weng D, Lien E. Inflammasomes and host defenses against bacterial infections. Curr Opin Microbiol. 2013;16:23-31.
16. Cui L, Qi Y, Li H, Ge Y, Zhao K, Qi X, et al. Serum microRNA expression profile distinguishes enterovirus 71 and coxsackievirus 16 infections in patients with hand-foot-and-mouth disease. PLoS One. 2011;6:27071.
17. Ni Y, Meng L, Wang L, Dong W, Shen H, Wang G, et al. MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma. Gene. 2013;517:197-204.
18. Pagliuca A, Valvo C, Fabrizi E, di Martino S, Biffoni M, Runci D, et al. Analysis of the combined action of MiR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression. Oncogene. 2012;10:1038.
19. Noguchi S, Yasui Y, Iwasaki J, Kumazaki M, Yamada N, Naito S, et al. Replacement treatment with microRNA-143 and - 145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways. Cancer Lett. 2013;328:353-61.
20. Akao Y, Nakagawa Y, Kitade Y, Kinoshita T, Naoe T. Downregulation of microRNAs-143 and -145 in B-cell malignancies. Cancer Sci. 2007;98:1914-20.
21. Pignot G, Cizeron-Clairac G, Vacher S, Susini A, Tozlu S, Vieillefond A, et al. Microrna expression profile in a large series of bladder tumors: Identification of a 3-mirna signature associated with aggressiveness of muscle-invasive bladder cancer. Int J Cancer. 2013;132:2479-91.